• 08: Antibody Response to RSV Vaccines in Immunocompromised Adults

  • Jan 17 2025
  • Durée: 12 min
  • Podcast

08: Antibody Response to RSV Vaccines in Immunocompromised Adults

Écouter gratuitement

Voir les détails du balado

  • Résumé

  • This study investigates the antibody response to respiratory syncytial virus (RSV) vaccines in immunocompromised individuals. Researchers measured antibody levels in a cohort of immunocompromised adults after receiving either an adjuvanted or non-adjuvanted RSV vaccine. Results showed heterogeneous antibody responses, with a significant portion not achieving seroconversion or a high-titer neutralization threshold. The adjuvanted vaccine showed better results. Study limitations included a small sample size and lack of cellular data. The findings suggest a need for further investigation into optimizing RSV vaccination strategies for immunocompromised populations.


    Created with NotebookLM by Google so there may be mistakes and/or errors.


    PMID: 39786402

    Karaba AH, Hage C, Sengsouk I, et al. Antibody Response to Respiratory Syncytial Virus Vaccination in Immunocompromised Persons. JAMA 2024.
    Voir plus Voir moins
Voir plus Voir moins

Ce que les auditeurs disent de 08: Antibody Response to RSV Vaccines in Immunocompromised Adults

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.

Évaluations sur Audible.ca

Évaluations sur Amazon.ca
Il n'y a pas encore de critiques pour ce titre.